Company:  HEAT BIOLOGICS, INC. (HTBX)
Form Type:  8-K
Filing Date:  12/7/2017 
CIK:  0001476963 
Address:  801 CAPITOLA DRIVE 
City, State, Zip:  DURHAM, North Carolina 27713 
Telephone:  919-240-7133 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$0.37  
Change: 
-0.0164 (-4.25%)  
Trade Time: 
11:26 AM EST  
Market Cap: 
$13.21M
Trade HTBX now with 

© 2017  
Description of Business
We are an immuno-oncology company developing novel therapies designed to activate a patient's immune system against cancer utilizing an engineered form of gp96. Heat's highly specific T cell-stimulating therapeutic vaccine platform technologies, ImPACT® (Immune Pan-Antigen Cytotoxic Therapy) and ComPACT(TM) (Combination Pan-Antigen Cytotoxic Therapy), form the basis of our product candidates. Our platform technologies address two synergistic mechanisms of action: activation and proliferation of CD8+ T cells, or "killer" T cells; and T cell co-stimulation. We believe the use of these technologies in combination with other immunotherapies has the potential to dramatically improve patient outcomes.
Register and access this filing in:     
  FORM 8-K
    SECTION 8 OTHER EVENTS
      Item 8.01 Other Events.
    SECTION 9 FINANCIAL STATEMENTS AND EXHIBITS
      Item 9.01 Financial Statements and Exhibits.
    SIGNATURES
  EXHIBIT 99.1